4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-022537
Chief Technical Officer sold 73,038 shares at an average $50.39 ($3,680,198)
- Chief Technical Officer acquired 73,408 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Option exercise 10b5-1 | +2,656 | 5,270 | D: show line 1 in the form | ||
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Option exercise 10b5-1 | +69,190 | $21.38 | $1,479,282 | 74,460 | D: show line 2 in the form |
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Sale 10b5-1 | −100 | $48.24 | $4,824 | 74,360 | D: show line 3 in the form |
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Sale 10b5-1 | −48,177 | $50.14 | $2,415,503 | 26,183 | D: show line 4 in the form |
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Sale 10b5-1 | −23,397 | $50.88 | $1,190,503 | 2,786 | D: show line 5 in the form |
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Sale 10b5-1 | −100 | $51.52 | $5,152 | 2,686 | D: show line 6 in the form |
| Shulman Joseph Chief Technical Officer | 2024-02-11 | Option exercise 10b5-1 | +1,562 | 4,248 | D: show line 7 in the form | ||
| Shulman Joseph Chief Technical Officer | 2024-02-12 | Sale 10b5-1 | −791 | $51.38 | $40,642 | 3,457 | D: show line 8 in the form |
| Shulman Joseph Chief Technical Officer | 2024-02-13 | Sale 10b5-1 | −473 | $49.84 | $23,574 | 2,984 | D: show line 9 in the form |
| Open-market sales · 73,038 sh · avg $50.39 · $3,680,198 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 5,312 | D: show line 10 in the form | ||
| Shulman Joseph Chief Technical Officer | 2024-02-09 | Option exercise · Stock Option (right to buy) 10b5-1 | −69,190 | 6,610 | D: show line 11 in the form | ||
| Shulman Joseph Chief Technical Officer | 2024-02-11 | Option exercise · Restricted Stock Units 10b5-1 | −1,562 | 1,562 | D: show line 12 in the form |
Loading xslF345X05/tm246165-2_4seq1.xml…